Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 2 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001449,SPRD/Ztm,female,102 days to 97 days,48,,CMO:0000345,post-insult time to mammary tumor formation,,,,43.8,d,0.1299,0.9,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11343,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",, 75,"Kurz SG, et al., Endocrinology. 2008 Apr 17",mammary gland integrity trait,,RS:0001161,ACI.COP-(D6Rat80-D6Rat146)/Shul,female,259 days to 0 days,17,,CMO:0000345,post-insult time to mammary tumor formation,,median,,165,d,,,MMO:0000158,manual palpation method,,0,,,,,17 beta-estradiol (27.5 mg) (for 196 days),11371,17 beta-estradiol (27.5 mg) (for 196 days),, 75,"Kurz SG, et al., Endocrinology. 2008 Apr 17",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,259 days to 0 days,21,,CMO:0000345,post-insult time to mammary tumor formation,,median,,145,d,,,MMO:0000158,manual palpation method,,0,,,,,17 beta-estradiol (27.5 mg) (for 196 days),11375,17 beta-estradiol (27.5 mg) (for 196 days),, 81,"Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,259 days to 143 days,22,,CMO:0000345,post-insult time to mammary tumor formation,,,,136,d,6.0,28.1425,MMO:0000158,manual palpation method,,0.0,,crystalline implant,,,17 beta-estradiol (27.5 mg) (between 193 and 199 days),11383,17 beta-estradiol (27.5 mg) (between 193 and 199 days),, 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,264 days to 206 days,31,,CMO:0000345,post-insult time to mammary tumor formation,,mean,,141,d,4.8493,27.0,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 147 and 195 days),11748,17 beta-estradiol (27.5 mg) (between 147 and 195 days),, 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,330 days to 212 days,7,,CMO:0000345,post-insult time to mammary tumor formation,,mean,,208,d,7.5593,20.0,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 212 and 330 days),11749,17 beta-estradiol (27.5 mg) (between 212 and 330 days),, 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,264 days to 206 days,31,,CMO:0000345,post-insult time to mammary tumor formation,,median,median,140,d,,,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 147 and 195 days),11750,17 beta-estradiol (27.5 mg) (between 147 and 195 days),, 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,330 days to 212 days,7,,CMO:0000345,post-insult time to mammary tumor formation,,median,median,195,d,,,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 212 and 330 days),11751,17 beta-estradiol (27.5 mg) (between 212 and 330 days),, 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,104 days to 99 days,46,,CMO:0000345,post-insult time to mammary tumor formation,,,,45.91,d,0.1873,1.27,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11345,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",, 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001452,SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm,female,112 days to 107 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,53.4,d,0.6414,2.4,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11344,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0000803,SS-Chr 3BN/Mcwi,female,162 days to 152 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,95.48,d,1.665,6.23,MMO:0000158,manual palpation method,,0,200 mg DMBA in 10 ml seame oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",11491,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0001486,SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi,female,162 days to 152 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,48.51,d,12.0668,45.15,MMO:0000158,manual palpation method,,0,200ng DMBA/10 ml seasme oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",65572,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0002482,SS.BN-(D6Rat149-D6Arb3)/Mcwi,female,162 days to 152 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,52.37,d,1.3203,4.94,MMO:0000158,manual palpation method,,0,200ng DMBA/10 ml seasme oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",65574,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 76,"Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,260 days to 160 days,21,,CMO:0000345,post-insult time to mammary tumor formation,,,serial mean,145,d,,,MMO:0000158,manual palpation method,mammary gland,0.0,,,,,17 beta-estradiol (27.5 mg) (between 99 and 197 days),66104,17 beta-estradiol (27.5 mg) (between 99 and 197 days),, 76,"Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,260 days to 160 days,21,,CMO:0000345,post-insult time to mammary tumor formation,,,median,143,d,,,MMO:0000158,manual palpation method,mammary gland,0.0,,,,,17 beta-estradiol (27.5 mg) (between 99 and 197 days),66111,17 beta-estradiol (27.5 mg) (between 99 and 197 days),, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0000809,SS-Chr 9BN/Mcwi,female,162 days to 152 days,40,,CMO:0000345,post-insult time to mammary tumor formation,,,,58.31,d,0.8522,5.39,MMO:0000158,manual palpation method,,0,200 mg DMBA in 10 ml seame oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",65567,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0000811,SS/JrHsdMcwi,female,162 days to 152 days,40,,CMO:0000345,post-insult time to mammary tumor formation,,,,79.8,d,0.5866,3.71,MMO:0000158,manual palpation method,,0,200ng DMBA/10 ml seasme oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",65568,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0000800,SS-Chr 19BN/Mcwi,female,162 days to 152 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,44.03,d,0.4116,1.54,MMO:0000158,manual palpation method,,0,200 mg DMBA in 10 ml seame oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",65569,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 86,"Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45",mammary gland integrity trait,,RS:0000795,SS-Chr 14BN/Mcwi,female,162 days to 152 days,14,,CMO:0000345,post-insult time to mammary tumor formation,,,,46.69,d,1.0851,4.06,MMO:0000158,manual palpation method,,0,200 mg DMBA in 10 ml seame oil,DMBA oral gavage,105,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",65570,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",, 81,"Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,259 days to 143 days,22,,CMO:0000345,post-insult time to mammary tumor formation,,,median,133,d,,,MMO:0000158,manual palpation method,,0,,crystalline implant,,,17 beta-estradiol (27.5 mg) (between 193 and 199 days),65763,17 beta-estradiol (27.5 mg) (between 193 and 199 days),, 1558,"Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7.",mammary gland integrity trait,,RS:0000064,Crl:CD(SD),female,365 days to 0 days,32,,CMO:0000345,post-insult time to mammary tumor formation,,,median,65,d,,,MMO:0000158,manual palpation method,,0.0,,,,,"maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)",76267,maternal milk (for 20 days),vehicle control condition (for 15 days),"7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)" 1558,"Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7.",mammary gland integrity trait,,RS:0000064,Crl:CD(SD),female,365 days to 0 days,34,,CMO:0000345,post-insult time to mammary tumor formation,,,median,53,d,,,MMO:0000158,manual palpation method,,0.0,,,,,"maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)",76268,maternal milk (for 20 days),bisphenol A (25 ug/kg) (for 15 days),"7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)" 1558,"Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7.",mammary gland integrity trait,,RS:0000064,Crl:CD(SD),female,365 days to 0 days,24,,CMO:0000345,post-insult time to mammary tumor formation,,,median,56.5,d,,,MMO:0000158,manual palpation method,,0.0,,,,,"maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)",76269,maternal milk (for 20 days),bisphenol A (250 ug/kg) (for 15 days),"7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days)"